MedDataX Logo

LAAO With DAPT Versus Antithrombotic Therapy

NCT ID: NCT03310801

Last Updated: 2017-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

480 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-08-01

Study Completion Date

2017-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will retrospectively review and compare clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Composite of stroke and major bleeding will be compared after adjusting those groups using inverse probability weighted model.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation Coronary Artery Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

left atrial appendage occlusion antithrombotic therapy atrial fibrillation percutaneous coronary intervention drug eluting stent

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LAAO with DAPT

patients with AF who underwent PCI and treated with LAAO(either ACP or Watchman) and DAPT

ACP or Watchman

Intervention Type PROCEDURE

Left atrial appnedage occlusion using ACP or Watchman

Conventional antithrombotic therapy

patients with AF who underwent PCI and treated with conventional antithrombotic therapy

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ACP or Watchman

Left atrial appnedage occlusion using ACP or Watchman

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with AF who underwent PCI and treated with LAAO and DAPT or conventional antithrombotic therapy

Exclusion Criteria

\-
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Severance Hospital

OTHER

Sponsor Role collaborator

Sejong General Hospital

OTHER

Sponsor Role collaborator

Gachon University Gil Medical Center

OTHER

Sponsor Role collaborator

Ulsan University Hospital

OTHER

Sponsor Role collaborator

Korea University Anam Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Cheol Woong Yu

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cheol Woong Yu, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Korea University Anam Hospital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LAAO with DAPT

Identifier Type: -

Identifier Source: org_study_id